Status:
COMPLETED
Impact of Perioperative Body Composition Abnormalities on Patient Outcomes After Liver Transplantation
Lead Sponsor:
Zhejiang University
Collaborating Sponsors:
First Affiliated Hospital of Zhejiang University
Shulan (Hangzhou) Hospital
Conditions:
Liver Transplantation
Body Composition
Eligibility:
All Genders
Brief Summary
Accumulating evidence suggests the prognostic significance of body composition in chronic diseases and neoplastic diseases. CT imaging-based body composition abnormalities are significantly associated...
Eligibility Criteria
Inclusion
- Adult patients undergoing deceased donor liver transplantation (DDLT) for the first time.
Exclusion
- Pediatric transplants
- Re-transplants
- Multi-organ transplants
- Liver cancer patients with macrovascular invasion or distant metastasis
- Patients who died within 30 days after transplantation
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
996 Patients enrolled
Trial Details
Trial ID
NCT06209775
Start Date
January 1 2015
End Date
December 31 2022
Last Update
January 17 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.